Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Short Bowel Syndrome Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 GLP-2
1.2.3 Growth Hormone
1.2.4 Glutamine
1.2.5 Others
1.3 Market by Application
1.3.1 Global Short Bowel Syndrome Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Short Bowel Syndrome Market Perspective (2018-2033)
2.2 Short Bowel Syndrome Growth Trends by Region
2.2.1 Global Short Bowel Syndrome Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Short Bowel Syndrome Historic Market Size by Region (2018-2023)
2.2.3 Short Bowel Syndrome Forecasted Market Size by Region (2024-2033)
2.3 Short Bowel Syndrome Market Dynamics
2.3.1 Short Bowel Syndrome Industry Trends
2.3.2 Short Bowel Syndrome Market Drivers
2.3.3 Short Bowel Syndrome Market Challenges
2.3.4 Short Bowel Syndrome Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Short Bowel Syndrome Players by Revenue
3.1.1 Global Top Short Bowel Syndrome Players by Revenue (2018-2023)
3.1.2 Global Short Bowel Syndrome Revenue Market Share by Players (2018-2023)
3.2 Global Short Bowel Syndrome Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Short Bowel Syndrome Revenue
3.4 Global Short Bowel Syndrome Market Concentration Ratio
3.4.1 Global Short Bowel Syndrome Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Short Bowel Syndrome Revenue in 2022
3.5 Short Bowel Syndrome Key Players Head office and Area Served
3.6 Key Players Short Bowel Syndrome Product Solution and Service
3.7 Date of Enter into Short Bowel Syndrome Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Short Bowel Syndrome Breakdown Data by Type
4.1 Global Short Bowel Syndrome Historic Market Size by Type (2018-2023)
4.2 Global Short Bowel Syndrome Forecasted Market Size by Type (2024-2033)
5 Short Bowel Syndrome Breakdown Data by Application
5.1 Global Short Bowel Syndrome Historic Market Size by Application (2018-2023)
5.2 Global Short Bowel Syndrome Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Short Bowel Syndrome Market Size (2018-2033)
6.2 North America Short Bowel Syndrome Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Short Bowel Syndrome Market Size by Country (2018-2023)
6.4 North America Short Bowel Syndrome Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Short Bowel Syndrome Market Size (2018-2033)
7.2 Europe Short Bowel Syndrome Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Short Bowel Syndrome Market Size by Country (2018-2023)
7.4 Europe Short Bowel Syndrome Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Short Bowel Syndrome Market Size (2018-2033)
8.2 Asia-Pacific Short Bowel Syndrome Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Short Bowel Syndrome Market Size by Region (2018-2023)
8.4 Asia-Pacific Short Bowel Syndrome Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Short Bowel Syndrome Market Size (2018-2033)
9.2 Latin America Short Bowel Syndrome Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Short Bowel Syndrome Market Size by Country (2018-2023)
9.4 Latin America Short Bowel Syndrome Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Short Bowel Syndrome Market Size (2018-2033)
10.2 Middle East & Africa Short Bowel Syndrome Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Short Bowel Syndrome Market Size by Country (2018-2023)
10.4 Middle East & Africa Short Bowel Syndrome Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Takeda
11.1.1 Takeda Company Detail
11.1.2 Takeda Business Overview
11.1.3 Takeda Short Bowel Syndrome Introduction
11.1.4 Takeda Revenue in Short Bowel Syndrome Business (2018-2023)
11.1.5 Takeda Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Short Bowel Syndrome Introduction
11.2.4 Merck Revenue in Short Bowel Syndrome Business (2018-2023)
11.2.5 Merck Recent Development
11.3 Emmaus Life Sciences
11.3.1 Emmaus Life Sciences Company Detail
11.3.2 Emmaus Life Sciences Business Overview
11.3.3 Emmaus Life Sciences Short Bowel Syndrome Introduction
11.3.4 Emmaus Life Sciences Revenue in Short Bowel Syndrome Business (2018-2023)
11.3.5 Emmaus Life Sciences Recent Development
11.4 Nutrinia
11.4.1 Nutrinia Company Detail
11.4.2 Nutrinia Business Overview
11.4.3 Nutrinia Short Bowel Syndrome Introduction
11.4.4 Nutrinia Revenue in Short Bowel Syndrome Business (2018-2023)
11.4.5 Nutrinia Recent Development
11.5 GlyPharma Therapeutics
11.5.1 GlyPharma Therapeutics Company Detail
11.5.2 GlyPharma Therapeutics Business Overview
11.5.3 GlyPharma Therapeutics Short Bowel Syndrome Introduction
11.5.4 GlyPharma Therapeutics Revenue in Short Bowel Syndrome Business (2018-2023)
11.5.5 GlyPharma Therapeutics Recent Development
11.6 OxThera
11.6.1 OxThera Company Detail
11.6.2 OxThera Business Overview
11.6.3 OxThera Short Bowel Syndrome Introduction
11.6.4 OxThera Revenue in Short Bowel Syndrome Business (2018-2023)
11.6.5 OxThera Recent Development
11.7 Ardelyx
11.7.1 Ardelyx Company Detail
11.7.2 Ardelyx Business Overview
11.7.3 Ardelyx Short Bowel Syndrome Introduction
11.7.4 Ardelyx Revenue in Short Bowel Syndrome Business (2018-2023)
11.7.5 Ardelyx Recent Development
11.8 Sancilio & Company
11.8.1 Sancilio & Company Company Detail
11.8.2 Sancilio & Company Business Overview
11.8.3 Sancilio & Company Short Bowel Syndrome Introduction
11.8.4 Sancilio & Company Revenue in Short Bowel Syndrome Business (2018-2023)
11.8.5 Sancilio & Company Recent Development
11.9 Naia Pharmaceuticals
11.9.1 Naia Pharmaceuticals Company Detail
11.9.2 Naia Pharmaceuticals Business Overview
11.9.3 Naia Pharmaceuticals Short Bowel Syndrome Introduction
11.9.4 Naia Pharmaceuticals Revenue in Short Bowel Syndrome Business (2018-2023)
11.9.5 Naia Pharmaceuticals Recent Development
11.10 Zealand Pharma
11.10.1 Zealand Pharma Company Detail
11.10.2 Zealand Pharma Business Overview
11.10.3 Zealand Pharma Short Bowel Syndrome Introduction
11.10.4 Zealand Pharma Revenue in Short Bowel Syndrome Business (2018-2023)
11.10.5 Zealand Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Short Bowel Syndrome Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of GLP-2
Table 3. Key Players of Growth Hormone
Table 4. Key Players of Glutamine
Table 5. Key Players of Others
Table 6. Global Short Bowel Syndrome Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Short Bowel Syndrome Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Short Bowel Syndrome Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Short Bowel Syndrome Market Share by Region (2018-2023)
Table 10. Global Short Bowel Syndrome Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Short Bowel Syndrome Market Share by Region (2024-2033)
Table 12. Short Bowel Syndrome Market Trends
Table 13. Short Bowel Syndrome Market Drivers
Table 14. Short Bowel Syndrome Market Challenges
Table 15. Short Bowel Syndrome Market Restraints
Table 16. Global Short Bowel Syndrome Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Short Bowel Syndrome Market Share by Players (2018-2023)
Table 18. Global Top Short Bowel Syndrome Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Short Bowel Syndrome as of 2022)
Table 19. Ranking of Global Top Short Bowel Syndrome Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Short Bowel Syndrome Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Short Bowel Syndrome Product Solution and Service
Table 23. Date of Enter into Short Bowel Syndrome Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Short Bowel Syndrome Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Short Bowel Syndrome Revenue Market Share by Type (2018-2023)
Table 27. Global Short Bowel Syndrome Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Short Bowel Syndrome Revenue Market Share by Type (2024-2033)
Table 29. Global Short Bowel Syndrome Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Short Bowel Syndrome Revenue Market Share by Application (2018-2023)
Table 31. Global Short Bowel Syndrome Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Short Bowel Syndrome Revenue Market Share by Application (2024-2033)
Table 33. North America Short Bowel Syndrome Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Short Bowel Syndrome Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Short Bowel Syndrome Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Short Bowel Syndrome Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Short Bowel Syndrome Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Short Bowel Syndrome Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Short Bowel Syndrome Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Short Bowel Syndrome Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Short Bowel Syndrome Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Short Bowel Syndrome Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Short Bowel Syndrome Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Short Bowel Syndrome Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Short Bowel Syndrome Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Short Bowel Syndrome Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Short Bowel Syndrome Market Size by Country (2024-2033) & (US$ Million)
Table 48. Takeda Company Detail
Table 49. Takeda Business Overview
Table 50. Takeda Short Bowel Syndrome Product
Table 51. Takeda Revenue in Short Bowel Syndrome Business (2018-2023) & (US$ Million)
Table 52. Takeda Recent Development
Table 53. Merck Company Detail
Table 54. Merck Business Overview
Table 55. Merck Short Bowel Syndrome Product
Table 56. Merck Revenue in Short Bowel Syndrome Business (2018-2023) & (US$ Million)
Table 57. Merck Recent Development
Table 58. Emmaus Life Sciences Company Detail
Table 59. Emmaus Life Sciences Business Overview
Table 60. Emmaus Life Sciences Short Bowel Syndrome Product
Table 61. Emmaus Life Sciences Revenue in Short Bowel Syndrome Business (2018-2023) & (US$ Million)
Table 62. Emmaus Life Sciences Recent Development
Table 63. Nutrinia Company Detail
Table 64. Nutrinia Business Overview
Table 65. Nutrinia Short Bowel Syndrome Product
Table 66. Nutrinia Revenue in Short Bowel Syndrome Business (2018-2023) & (US$ Million)
Table 67. Nutrinia Recent Development
Table 68. GlyPharma Therapeutics Company Detail
Table 69. GlyPharma Therapeutics Business Overview
Table 70. GlyPharma Therapeutics Short Bowel Syndrome Product
Table 71. GlyPharma Therapeutics Revenue in Short Bowel Syndrome Business (2018-2023) & (US$ Million)
Table 72. GlyPharma Therapeutics Recent Development
Table 73. OxThera Company Detail
Table 74. OxThera Business Overview
Table 75. OxThera Short Bowel Syndrome Product
Table 76. OxThera Revenue in Short Bowel Syndrome Business (2018-2023) & (US$ Million)
Table 77. OxThera Recent Development
Table 78. Ardelyx Company Detail
Table 79. Ardelyx Business Overview
Table 80. Ardelyx Short Bowel Syndrome Product
Table 81. Ardelyx Revenue in Short Bowel Syndrome Business (2018-2023) & (US$ Million)
Table 82. Ardelyx Recent Development
Table 83. Sancilio & Company Company Detail
Table 84. Sancilio & Company Business Overview
Table 85. Sancilio & Company Short Bowel Syndrome Product
Table 86. Sancilio & Company Revenue in Short Bowel Syndrome Business (2018-2023) & (US$ Million)
Table 87. Sancilio & Company Recent Development
Table 88. Naia Pharmaceuticals Company Detail
Table 89. Naia Pharmaceuticals Business Overview
Table 90. Naia Pharmaceuticals Short Bowel Syndrome Product
Table 91. Naia Pharmaceuticals Revenue in Short Bowel Syndrome Business (2018-2023) & (US$ Million)
Table 92. Naia Pharmaceuticals Recent Development
Table 93. Zealand Pharma Company Detail
Table 94. Zealand Pharma Business Overview
Table 95. Zealand Pharma Short Bowel Syndrome Product
Table 96. Zealand Pharma Revenue in Short Bowel Syndrome Business (2018-2023) & (US$ Million)
Table 97. Zealand Pharma Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Short Bowel Syndrome Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Short Bowel Syndrome Market Share by Type: 2022 VS 2033
Figure 3. GLP-2 Features
Figure 4. Growth Hormone Features
Figure 5. Glutamine Features
Figure 6. Others Features
Figure 7. Global Short Bowel Syndrome Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Short Bowel Syndrome Market Share by Application: 2022 VS 2033
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Short Bowel Syndrome Report Years Considered
Figure 12. Global Short Bowel Syndrome Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Short Bowel Syndrome Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Short Bowel Syndrome Market Share by Region: 2022 VS 2033
Figure 15. Global Short Bowel Syndrome Market Share by Players in 2022
Figure 16. Global Top Short Bowel Syndrome Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Short Bowel Syndrome as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Short Bowel Syndrome Revenue in 2022
Figure 18. North America Short Bowel Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Short Bowel Syndrome Market Share by Country (2018-2033)
Figure 20. United States Short Bowel Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Short Bowel Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Short Bowel Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Short Bowel Syndrome Market Share by Country (2018-2033)
Figure 24. Germany Short Bowel Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Short Bowel Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Short Bowel Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Short Bowel Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Short Bowel Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Short Bowel Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Short Bowel Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Short Bowel Syndrome Market Share by Region (2018-2033)
Figure 32. China Short Bowel Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Short Bowel Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Short Bowel Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Short Bowel Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Short Bowel Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Short Bowel Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Short Bowel Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Short Bowel Syndrome Market Share by Country (2018-2033)
Figure 40. Mexico Short Bowel Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Short Bowel Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Short Bowel Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Short Bowel Syndrome Market Share by Country (2018-2033)
Figure 44. Turkey Short Bowel Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Short Bowel Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Takeda Revenue Growth Rate in Short Bowel Syndrome Business (2018-2023)
Figure 47. Merck Revenue Growth Rate in Short Bowel Syndrome Business (2018-2023)
Figure 48. Emmaus Life Sciences Revenue Growth Rate in Short Bowel Syndrome Business (2018-2023)
Figure 49. Nutrinia Revenue Growth Rate in Short Bowel Syndrome Business (2018-2023)
Figure 50. GlyPharma Therapeutics Revenue Growth Rate in Short Bowel Syndrome Business (2018-2023)
Figure 51. OxThera Revenue Growth Rate in Short Bowel Syndrome Business (2018-2023)
Figure 52. Ardelyx Revenue Growth Rate in Short Bowel Syndrome Business (2018-2023)
Figure 53. Sancilio & Company Revenue Growth Rate in Short Bowel Syndrome Business (2018-2023)
Figure 54. Naia Pharmaceuticals Revenue Growth Rate in Short Bowel Syndrome Business (2018-2023)
Figure 55. Zealand Pharma Revenue Growth Rate in Short Bowel Syndrome Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed